Stocks · News reference
Congressman with $11.5 Million in Trades Keeps Selling Stocks: Here’s the Latest Moves
A member of Congress continues to sell stocks, with no buys since 2024. Here are the latest names traded.
Reference Details
Connected Markets
Poisar stores the source's headline, summary and market tags for reference. Reporting and full article text remain with the original publisher.
- Source
- benzinga
- Observed
- Checked
- Cadence
- Captured once, then retained as an archive reference
- Status
- fresh
Keep reading
Related Headlines
AbbVie vs. Pfizer: Which Dividend Stock Is the Better Buy in September?
The article compares two pharmaceutical dividend stocks: AbbVie and Pfizer. AbbVie is a Dividend King with 50+ consecutive years of dividend increases, offering a 2.6% yield and $18 billion in free cash flow, with strong growth from immunology products like Rinvoq and Skyrizi. Pfizer is in recovery mode post-pandemic, offering a higher 6.2% dividend yield but with less consistent growth. The author recommends AbbVie as the better dividend buy due to its proven ability to grow dividends sustainably and demonstrated business resilience after losing Humira exclusivity.
AbbVie Receives European Commission Approval Of RINVOQ For Children With Active Polyarticular Juvenile Idiopathic Arthritis Aged Two And Older
RINVOQ is now approved in the European Union for the treatment of active polyarticular juvenile idiopathic arthritis (pJIA) in patients two years of age and older who have responded inadequately to, or who are
Bloom Energy vs. Eos Energy Enterprises: Which Energy Storage Stock Is a Better Buy in 2026?
The article compares two energy storage companies: Bloom Energy, a mature fuel cell provider with strong partnerships and profitability, and Eos Energy Enterprises, an emerging zinc-based battery manufacturer with explosive revenue growth but significant losses. Despite Bloom's higher valuation multiples, Eos is recommended for its attractive P/S ratio, recent business advances, and strong 2026 pipeline, while Bloom benefits from the AI datacenter boom with expected 85% revenue growth.
Warren Buffett's Farewell: What Investors Can Learn From His Biggest Mistake
Warren Buffett stepped down as Berkshire Hathaway chairman after six decades of exceptional returns. The article argues his biggest mistake was failing to invest in Google early despite recognizing its strong business model through GEICO's advertising costs. Buffett finally invested in Alphabet in 2025, illustrating the importance of acting on unique insights and specialized knowledge when investment opportunities arise.
Invest Like Buffett: Lessons From the Oracle of Omaha
Following Warren Buffett's step down as chairman of Berkshire Hathaway, the article explores his investment philosophy emphasizing long-term ownership, high-quality businesses with economic moats, and low-cost index funds. Buffett's approach has delivered nearly double the S&P 500's returns over six decades. The article highlights his preference for index funds over active management, focus on companies with durable competitive advantages, and recent increased investments in Japanese trading houses.